SCHEMBL7526323

SCHEMBL7526323

Cn1nc(-c2c(F)cccc2Cl)nc1-c1sc(Br)c(Cl)c1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.34
PDE10A Q9Y233 1/20 0.34
HTT P42858 2/20 0.33
GAA P10253 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NR1H2 P55055 2/20 0.33
NR1H3 Q13133 2/20 0.33
KMT2A Q03164 1/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
PTGES O14684 5/20 0.31
ACHE P22303 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNA4 P43681 1/20 0.31
KDM4E B2RXH2 1/20 0.31
USP2 O75604 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5726642 0.92 PDE2A (0.33) PDE2APDE10AHTTGAALMNA
SCHEMBL7477967 0.92 NR1H2 (0.36) NR1H2NR1H3NPC1RAB9ATRPM8
SCHEMBL5202844 0.88 PDE2A (0.35) PDE2APDE10AHTTLMNAMAPK1
SCHEMBL6073454 0.87 PDE2A (0.33) PDE2APDE10AHTTGAALMNA
SCHEMBL7532307 0.85 PDE2A (0.33) PDE2APDE10AHTTLMNAMAPK1
SCHEMBL6976971 0.83 GAA (0.35) PDE2APDE10AHTTGAALMNA
SCHEMBL5727053 0.83 PDE2A (0.33) PDE2APDE10AHTTGAALMNA
SCHEMBL5727601 0.81 PTGES (0.39) PDE2APDE10AGAANR1H2NR1H3
SCHEMBL6972041 0.81 PDE2A (0.34) PDE2APDE10AHTTGAALMNA
SCHEMBL2933280 0.81 PDE2A (0.34) PDE2APDE10AHTTGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6417187-B2 PALLADIUM CATALYZED ARYLATION, ALKYLATION, DEIODINATION OR DEBROMINATION DOW AGROSCIENCES LLC 2002-07-09 US disclosed
US-20020019370-A1 Palladium catalyzed arylation, alkylation, deiodination or debromination DOW AGROSCIENCES LLC 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019370-A1 Palladium catalyzed arylation, alkylation, deiodination or debromination DDT, TYR, DDC PDE2A 1550/4885PDE10A 1626/4885HTT 2843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.